Table 1 KEGG enrichment of three stages following infection
Time | Description | Number | Pvalue | |
|---|---|---|---|---|
0v3 | up | Ribosome | 69 | 1.27 × 10–18 |
Valine, leucine and isoleucine biosynthesis | 11 | 6.84 × 1005 | ||
Lysine biosynthesis | 9 | 1.99 × 10–4 | ||
Citrate cycle (TCA cycle) | 16 | 3.14 × 10–4 | ||
Pyruvate metabolism | 21 | 8.88 × 10–4 | ||
down | Prodigiosin biosynthesis | 5 | 7.37 × 10–5 | |
Linoleic acid metabolism | 3 | 3.33 × 10–3 | ||
Protein processing in endoplasmic reticulum | 23 | 2.113 × 10–3 | ||
Longevity regulating pathway—multiple species | 11 | 1.439 × 10–3 | ||
Ubiquitin mediated proteolysis | 18 | 3.151 × 10–3 | ||
0v4 | up | Ribosome | 56 | 2.05 × 10–11 |
Valine, leucine and isoleucine degradation | 26 | 1.55 × 10–6 | ||
Galactose metabolism | 20 | 3.22 × 10–5 | ||
beta-Alanine metabolism | 17 | 8.22 × 10–5 | ||
Pentose and glucuronate interconversions | 18 | 6.03 × 10–5 | ||
down | Prodigiosin biosynthesis | 5 | 2.048 × 10–4 | |
Mitophagy—yeast | 13 | 3.6298 × 10–3 | ||
Necroptosis | 10 | 3.088 × 10–3 | ||
Ubiquitin mediated proteolysis | 21 | 2.3468 × 10–3 | ||
Fatty acid biosynthesis | 6 | 7.4068 × 10–3 | ||
0v5 | up | Ribosome | 64 | 2.078 × 10–15 |
Galactose metabolism | 22 | 4.088 × 10–6 | ||
Starch and sucrose metabolism | 33 | 8.518 × 10–6 | ||
Valine, leucine and isoleucine degradation | 25 | 2.028 × 10–5 | ||
N-Glycan biosynthesis | 20 | 8.18 × 10–5 | ||
down | Prodigiosin biosynthesis | 5 | 3.088 × 10–4 | |
Mitophagy—yeast | 15 | 7.498 × 10–4 | ||
Basal transcription factors | 13 | 2.858 × 10–3 | ||
Ubiquitin mediated proteolysis | 21 | 6.528 × 10–3 | ||
Linoleic acid metabolism | 3 | 7.8518 × 10–3 | ||